David W. Bearl

David W. Bearl

Auto-generated profile, based on publicly available information

David W. Bearl

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2010 in Vision Research
Verified
Journal Article
Closed access
GGGeoffrey M. Ghose
Geoffrey M. Ghose
DBDavid W. Bearl
David W. Bearl

18 January 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JEJonathan B Edelson
Jonathan B Edelson
ARAlexander Raskin
Alexander Raskin
MAMohammed Absi
Mohammed Absi
IAIki Adachi
Iki Adachi
OAOthman Aljohani
Othman Aljohani
ACAction Collaborators
Action Collaborators

30 March 2022 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
JSJonathan H. Soslow
Jonathan H. Soslow
JGJustin Godown
Justin Godown
DBDavid W. Bearl
David W. Bearl
KCKimberly Crum
Kimberly Crum
JSJames C. Slaughter
James C. Slaughter
LHLazaro Hernandez
Lazaro Hernandez

25 March 2018 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
JGJustin Godown
Justin Godown
DDDebra A. Dodd
Debra A. Dodd
MSMichael Stanley
Michael Stanley
CHCorey Havens
Corey Havens
MXMeng Xu
Meng Xu
JSJonathan H. Soslow
Jonathan H. Soslow

12 November 2020 in ASAIO Journal
Verified
Journal Article
Closed access
DBDavid W. Bearl
David W. Bearl
BFBrian Feingold
Brian Feingold
ALAngela Lorts
Angela Lorts
DRDavid Rosenthal
David Rosenthal
FZFarhan Zafar
Farhan Zafar
JGJustin Godown
Justin Godown
Discharging children on ventricular assist device (VAD) support offers advantages for quality of life. We sought to describe discharge and readmission frequency in children on VAD support. All VAD-implanted patients aged 10–21 years at Advanced Cardiac Therapies Improving Outcomes Network (ACTION) centers were identified from the Pediatric Health Information System database (2009–2018). Discharge frequency on VAD was calculated. Patients discharged on VAD were compared with those not discharged. Freedom from readmission was assessed using the Kaplan–Meier method. A total of 298 VAD-implanted patients from 25 centers were identified, of which 163 (54.7%) were discharged. Discharges increased over time (36.9% [2009–2012] vs. 59.7% [2013–2018], p = 0.001). Of 144 discharged patients with follow-up, 96 (66.7%) were readmitted for reasons other than transplantation. Heart failure was the most common reason for readmission (27.7%), followed by infection (25.8%) and hematologic concerns (16.8%). In-hospital mortality on readmission was uncommon (1.8%) and the median length of stay was 6 days (interquartile range 2–19 days). Discharge of children on VAD support has increased over time, although variability exists across centers. Readmissions are common with diverse indications; however, the risk of mortality is low. Further interventions, including collaboration in ACTION, are critical to increasing discharges and optimizing outpatient management.

11 February 2015 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
DBDavid W. Bearl
David W. Bearl
LMLuAnn Mill
LuAnn Mill
JKJohn D. Kugler
John D. Kugler
JPJohn L. Prusmack
John L. Prusmack
CEChristopher C. Erickson
Christopher C. Erickson
Catheter ablation of the slow atrioventricular (AV) pathway has been shown to be safe and effective in pediatric patients with atrioventricular nodal reentrant tachycardia (AVNRT). Despite that, acute success is not guaranteed, and safety of ablating near the AV node remains a concern. A retrospective analysis was performed of all AVNRT ablations using the Ensite NavX voltage mapping technique at our institution. Each map was reviewed with patient and NavX computer data recorded. To account for a learning curve, each map was idealized and compared with the original map. Procedure and fluoroscopy time were compared with a control group. Twenty-eight patients underwent catheter ablation for AVNRT from September 2011 until December 2012 using the voltage mapping technique. The historical control group comprised 24 patients who underwent catheter ablation using the electroanatomic approach. There was 96% acute success with one recurrence in the voltage mapping group, at a mean follow-up of 24 months. The slow pathway was visualized in 86% of patients at the time of ablation, while three of four without could be found on idealization of the voltage map. Mean high- and low-voltage parameters increased with idealization, but showed no correlation with age, gender, or weight. Estimated pathway size had significant inter-patient variability. Procedure and fluoroscopy times did not vary significantly compared with controls. Visualization of the AV nodal slow pathway in a pediatric population is possible using voltage mapping technique with the potential to increase safety and efficacy. Variability exists in the voltage parameters needed to visualize individual slow pathways, which leads to a distinct learning curve.